Rating Change
William Blair analysts initiated coverage on Wave Life Sciences Ltd. (NASDAQ:WVE) with a rating of Outperform on October 16, 2026.
new coverageNASDAQ:WVE
William Blair Initiates Coverage on Wave Life Sciences Ltd. (WVE) with Outperform
William Blair analysts initiated coverage on Wave Life Sciences Ltd. (NASDAQ:WVE) with a rating of Outperform on October 16, 2026.
At publication ·
What changed
Wave Life Sciences Ltd. (NASDAQ:WVE) · new coverage
- Firm
- William Blair
- Rating
- Outperform
- Price at event
- $3.13
- Market capitalization
- $2.7B
At a glance
Key takeaways
- William Blair initiated Outperform coverage on Wave Life Sciences (WVE) on October 16, 2026, with the stock trading at $3.13 and a market capitalization of $2.7 billion.
Market Context
Wave Life Sciences Ltd. operates in the Healthcare sector. The stock currently trades at $3.13 with a market capitalization of $2.7B.
Analyst coverage from William Blair provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Wave Life Sciences Ltd.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Wave Life Sciences Ltd.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 16, 2026 | William Blair | Outperform | N/A |
| Oct 15, 2026 | UBS | Buy | N/A |
| Oct 01, 2026 | Ladenburg Thalmann | Buy | N/A |
| Sep 23, 2026 | JP Morgan | Neutral | N/A |
| Aug 04, 2026 | Mizuho | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View WVE Stock Page
Frequently Asked Questions
What does the Outperform rating mean for WVE?
A rating of Outperform from William Blair reflects the analyst's outlook on Wave Life Sciences Ltd. (NASDAQ:WVE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the WVE forecast page.